Pharmacology and Neurological Conditions Flashcards
Why do PT’s need to know pharmacology?
How to _____ ____ medication
How to understand the _____ of ________
How to find _____ _______
What do these ______ _____ mean for practice?
look up
mechanism; action
side effects
side effects
Pharmacology and Neurorehabilitation
Types of medications
Those acting on the ______ ______, ______, ________ ______
Those used in prevention of ________ ________ to the nervous system
Those used in treatment of _______ _______ that could impact the nervous system
Those used to treat ________ ________ of nervous system impairment
nervous system, brain, spinal cord
adverse events
secondary conditions
secondary complications
CVA:
Acute management
__________
clotting
TBI:
Acute management
________ _________
secondary complications
MS:
Acute management
________ __________ medications
disease modifying
We are looking at the ________ _________ goals not PT management goals
pharmacologic management
Outputs from the ________ get to the body in a two-part ______
CNS; circuit
UMNs are contained in the _________
CNS
LMNs are contained in the ________
PNS
UMN symptoms:
Generally _____ T12
_______reflexia
________tone/spasticity
Postive ______ signs
_______ or ________ bladder and bowel
above
hyper
increased
UMN
spastic; hyperreflexive
LMN symptoms:
Generally _____ T12
______reflexia
_________
___________ tone/spasticity
________ UMN signs
________ bladder and bowel
below
hypo
flaccidity
decreased
negative
flaccid
CVA:
This disorder is caused by an _______ of _________ _________
irregularity; blood supply
CVA:
A bleed = _______
A clot = ________
hemorrhagic
ischemic
An ischemic stroke can possibly be reversed with this medication?
tPA (Tissue Plasminogen Activator)
tPA is a ___________
thrombolytic
tPA’s mechanism of action: initiates fibronolysis by binding to fibrin and thrombus, which means what…?
It helps break down clots
tPA should be administered within what hours of an ischemic event?
3-4.5 hours
tPA is given after ____ or ______ and _______ _______ monitoring to ensure it is ischemic
CT; MRI
blood glucose
Contraindications to tPA:
Active ________ ________
Suspected _______ _______
Recent (within 3 months) _______ or _________ surgery or severe ________ ______
__________ hemorrhage
_______ stroke within the last 3 months
internal bleeding
aortic dissection
intracranial; intraspinal
head trauma
subarachnoid
Ischemic
What is the main risk of tPA?
hemorrhage
If the problem in ischemic CVA is a clot or embolus, medication should target ________
anticoagulation
Heparin is typically administered by ?
IV (hospital)
injection
________ MOA: works to prevent 2 steps in the clotting cascade from happening
Heparin
With Heparin, it’s not always routine post ______ but can be used if there is concern for _______ _______
CVA
secondary emboli
What is the main risk/side effect for Heparin, Lovenox, and Coumadin?
hemorrhage
PT implications for Heparin:
Check ____/______/_____
At risk for ________ hemorrhage
Not a line you should _______ for mobility!
PT/PTT/INR
uncontrolled
disconnect
Lovenox is typically administered by _____ and rarely _____
Injection
IV
Lovenox MOA: is a low molecular weight _____, meaning it works the same way but has less effect on _______ compared to heparin and has a longer _____ ______
heparin
thrombin
half life
PT Implications for Lovenox:
Check _____/______/______
At risk for uncontrolled _______
PT/PTT/INR
hemorrhage
Coumadin is administered _________
orally
Coumadin MOA: depletes functional Vitamin _____ availability necessary for ________ of certain clotting factors
K
synthesis
Coumadin is often for more _______ stages
-treatment of ______ disorders
- __________ of _____________ complications
chronic
cardiac
prophylaxis; thromboembolic
PT implictions for Coumadin:
Check _____/_________/______
At risk for _________ hemorrhage
PT/PTT/INR
uncontrolled
INR stands for ?
International Normalizing Ratio